Construction and functional activity of a recombinant vector expressing rat glutamic acid decarboxylase 65

被引:1
作者
Liu, Jian-Sheng [1 ]
Wang, Qian [3 ]
Zhang, Ji-Bo [1 ]
Kong, Ling-Ju [1 ]
Yao, Su-Yan [2 ]
Zheng, De-Yu [1 ]
Xu, Qun-Yuan [4 ]
机构
[1] Liaoning Med Univ, Dept Anat, Jinzhou 121001, Peoples R China
[2] Liaoning Med Univ, Dept Pathophysiol, Jinzhou 121001, Peoples R China
[3] Liaoning Med Univ, Dept Radiol, Affiliated Hosp 1, Jinzhou 121001, Peoples R China
[4] Capital Med Univ, Beijing Inst Neurosci, Beijing 100069, Peoples R China
关键词
PARKINSONS-DISEASE; BASAL GANGLIA; GENE-TRANSFER; THERAPY; MODEL;
D O I
10.1007/s12264-011-1840-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective Glutamic acid decarboxylase 2 (GAD65) is a gamma-aminobutyric acid (GABA) synthetase. This study aimed to construct a recombinant lentivirus-rGAD65 (rLV-rGAD65) vector containing the cDNA of rat GAD65 (rGAD65) and assess its functional activity in vitro and in vivo. Methods cDNA of rGAD65 was amplified by RT-PCR and subcloned into the LV vector, forming the rLV-GFP-rGAD65 plasmid. The recombinant lentivirus particles (rLVrGAD65) were packaged by the LV Helper-Free System and the titer was measured. Primary rat lung fibroblasts were transfected with rLV-rGAD65. The expression of rGAD65 in fibroblasts was detected by immunocytochemistry and western blot and the level of GABA in the medium was assessed by high-performance liquid chromatograph (HPLC). In vivo, rLV-rGAD65 was injected into the subthalamic nucleus (STN) of Sprague-Dawley rats using stereotaxic methods, and rGAD65 protein levels in the STN were assessed by immunohistochemistry and Western blot, while the GABA concentration in the substantia nigra pars reticulata (SNr) was assayed by HPLC.Results The sequence of rGAD65 cDNA was in accord with that in GenBank. The amino-acid sequence of rGAD65 had no mutations and the titer of rLVrGAD65 reached 6.8 x 10(8)/mL. The efficiency of infection of fibroblasts was 80%, and the concentration of GABA in the medium was (48.14 +/- 9.35) nmol/L. In vivo, rGAD65 expression was detected in the STN, and the concentration of GABA in the SNr increased from (5.95 +/- 1.09) to (12.44 +/- 3.79) nmol/g tissue. Conclusion The recombinant LVGFP-rGAD65 vector was successfully constructed. rLV-rGAD65-infected primary fibroblasts in vitro and the expressed rGAD65 catalyzed the formation of GABA from glutamic acid. In vivo, the concentration of GABA in the SNr was increased after rLV-rGAD65 injection into the STN.
引用
收藏
页码:430 / 435
页数:6
相关论文
共 9 条
[1]   Experimental models of Parkinson's disease [J].
Beal, MF .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (05) :325-332
[2]   From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control [J].
Boraud, T ;
Bezard, E ;
Bioulac, B ;
Gross, CE .
PROGRESS IN NEUROBIOLOGY, 2002, 66 (04) :265-283
[3]   VERTEILUNG VON NORADRENALIN UND DOPAMIN (3-HYDROXYTYRAMIN) IM GEHIRN DES MENSCHEN UND IHR VERHALTEN BEI ERKRANKUNGEN DES EXTRAPYRAMIDALEN SYSTEMS [J].
EHRINGER, H ;
HORNYKIEWICZ, O .
KLINISCHE WOCHENSCHRIFT, 1960, 38 (24) :1236-1239
[4]   From experimentation to the surgical treatment of Parkinson's disease: Prelude or suite in basal ganglia research? [J].
Gross, CE ;
Boraud, T ;
Guehl, D ;
Bioulac, B ;
Bezard, E .
PROGRESS IN NEUROBIOLOGY, 1999, 59 (05) :509-532
[5]   Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer [J].
Kirik, D ;
Georgievska, B ;
Burger, C ;
Winkler, C ;
Muzyczka, N ;
Mandel, RJ ;
Björklund, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (07) :4708-4713
[6]   Subthalamic GAD gene therapy in a Parkinson's disease rat model [J].
Luo, J ;
Kaplitt, MG ;
Fitzsimons, HL ;
Zuzga, DS ;
Liu, YH ;
Oshinsky, ML ;
During, MJ .
SCIENCE, 2002, 298 (5592) :425-429
[7]   Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease [J].
Mandel, RJ ;
Snyder, RO ;
Leff, SE .
EXPERIMENTAL NEUROLOGY, 1999, 160 (01) :205-214
[8]   Viral vectors for gene therapy [J].
Robbins, PD ;
Tahara, H ;
Ghivizzani, SC .
TRENDS IN BIOTECHNOLOGY, 1998, 16 (01) :35-40
[9]   Update on Parkinson disease [J].
Siderowf, A ;
Stern, M .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (08) :651-658